SRS Capital Advisors Inc. Grows Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

SRS Capital Advisors Inc. boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,602 shares of the company’s stock after purchasing an additional 175 shares during the period. SRS Capital Advisors Inc.’s holdings in GE HealthCare Technologies were worth $125,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Farther Finance Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 10.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 4,520 shares of the company’s stock worth $424,000 after buying an additional 443 shares during the last quarter. Janney Montgomery Scott LLC purchased a new stake in GE HealthCare Technologies during the third quarter valued at about $4,367,000. Intact Investment Management Inc. acquired a new stake in GE HealthCare Technologies during the third quarter worth about $73,000. National Pension Service raised its holdings in shares of GE HealthCare Technologies by 15.8% in the 3rd quarter. National Pension Service now owns 716,002 shares of the company’s stock worth $67,197,000 after purchasing an additional 97,826 shares during the period. Finally, Asset Management One Co. Ltd. lifted its stake in shares of GE HealthCare Technologies by 0.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 164,750 shares of the company’s stock valued at $15,462,000 after purchasing an additional 1,507 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC opened at $84.76 on Thursday. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The firm has a market cap of $38.76 billion, a price-to-earnings ratio of 19.58, a PEG ratio of 3.19 and a beta of 1.15. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The company has a fifty day simple moving average of $86.52 and a 200 day simple moving average of $86.13.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on GEHC shares. Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.